Several studies have explored the potential of NLRP1 as a prognostic biomarker in various cancers, including lung adenocarcinoma [45, 46, 50], gastric cancer [51], prostate cancer [49], pancreatic cancer [52, 53], head and neck squamous cell carcinoma [54], and laryngeal carcinoma [55]. This evidence concerns the gene NLRP1 and familial pancreatic carcinoma.